Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

A comprehensive genomic analysis in more than 200 patients with metastatic urothelial carcinomas may help inform how a patient would respond to immunotherapy, report UNC Lineberger Comprehensive Cancer Center researchers and colleagues. About 90% of urothelial carcinomas are bladder cancers. These results, derived from a computational model based on the initial molecular findings of the UC-GENOME study, are published in Nature Communications.

Down syndrome, like Alzheimer’s, is a double-prion disorder

Previous article

‘Disenchanted’ review: Amy Adams returns, but the magic is gone

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations